Table 21: Dataset - stage complete

Completeness of the dataset (%) - stage complete by cancer site groups summary (persons)
Country average (population) Country average (country) England Scotland Northern Ireland Wales
All invasive xnmsc 79.9% 77.2% 81.3% 67.6% 80.4% 79.6%
Haematology 61.6% 46.2% 67.1% 0.0% 55.0% 62.8%
Head and Neck 87.4% 85.9% 88.8% 75.5% 92.3% 87.2%
Lower GI 87.1% 85.1% 88.4% 73.4% 86.7% 92.0%
Upper GI 79.0% 78.3% 79.5% 72.0% 78.9% 82.8%
HPB 71.1% 68.8% 72.1% 63.3% 71.8% 67.8%
Bronchus & Lung 93.0% 92.6% 93.1% 92.8% 92.3% 92.2%
Melanoma of skin 88.3% 77.6% 93.0% 37.9% 88.7% 90.9%
Breast 91.1% 89.4% 91.9% 87.0% 96.7% 82.0%
Cervix 89.8% 94.0% 88.5% 94.5% 96.8% 96.3%
Other Female Genitals 86.4% 85.7% 87.4% 71.6% 93.5% 90.4%
Prostate 89.5% 88.4% 89.9% 82.4% 87.4% 93.7%
Bladder 83.2% 79.4% 85.2% 61.1% 89.4% 82.1%
Kidney 83.1% 81.8% 84.2% 73.9% 90.0% 79.1%
Thyroid and other endocrine glands 76.8% 74.8% 77.8% 67.4% 88.4% 65.5%
Other invasive cancer 56.7% 44.2% 61.0% 20.9% 47.3% 47.7%
Non-Melanoma Skin Cancer 1.3% 0.9% 1.4% 0.0% 1.4% 0.5%